Specimen SS-F-BTR-528 // ZERO-BITTER · IFI-B
Naringin Reduc · T1 Cell-Free-B
Citrus sinensis
Orange
Target Trait
40%
% reduction
Naringin reduction
Technical Specifications
SKU
SS-F-BTR-528
Genomic Edits
4
GC Content
46.0%
Construct Length
2,727 bp
Promoter System
T7 / SP6 RNA polymerase
Expression System
Cell-free in vitro transcription/translation
Host Strain
In vitro wheat germ extract
Receptor Target
TAS2R38 (suppression)
IFI Score
40
Pathway Edits
- RhaT rhamnosyltransferase RNAi prevents final rhamnosylation of naringenin-7-glucoside to bitter naringin
- GT1 glucosyltransferase alternative isoform redirects naringenin to non-bitter glycoside conjugates
- CHS chalcone synthase RNAi reduces total naringenin precursor pool available for glycosylation
- CHI chalcone isomerase modification channels chalcone flux away from naringenin accumulation
Key Interventions
IFI Subscale Profile
IFI Profile
Use Case
Tier I Citrus sinensis lines with validated naringin reduction for fresh juice processing, citrus-flavored beverages, and functional food applications where grapefruit-like bitterness would otherwise activate TAS2R38 to objectionable levels.
License
$349 · Tier I License
Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.
Already purchased?